Janus kinase 2 V617F mutation in an unrelated peripheral blood stem cell donor
Polycythemia vera (PV) is relatively uncommon in early adulthood, and evidence about the prevalence of the Janus kinase 2 (JAK2) V617F mutation in the general population is limited. Here, we report a previously healthy volunteer peripheral blood stem cell (PBSC) donor who developed symptomatic PV wi...
Saved in:
| Main Authors: | Shang-Hsien Yang, Hsiang-Lin Wan, Ming-Hui Gu, Tso-Fu Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Tzu Chi Medical Journal |
| Subjects: | |
| Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2019;volume=31;issue=1;spage=60;epage=62;aulast=Yang |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01) -
Revised myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
by: Mohan B Agarwal, et al.
Published: (2018-01-01) -
Study of Patients with Polycythemia Vera in JAK2V617F and Mutated and Unmutated Status along with their Anxiety and Worried Thoughts: A Single-center Experience from Eastern India
by: Rishu Vidhatri, et al.
Published: (2024-12-01) -
All we know about polycythemia vera: literature review and own experience
by: K. M. Abdulkadyrov, et al.
Published: (2015-10-01) -
A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera
by: Chiho Furuya, et al.
Published: (2024-12-01)